{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:36:30Z","timestamp":1779294990370,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12035-019-01656-z","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T20:03:31Z","timestamp":1560369811000},"page":"8109-8123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Neuroprotective Effects of AG490 in Neonatal Hypoxic-Ischemic Brain Injury"],"prefix":"10.1007","volume":"56","author":[{"given":"Feiya","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Turlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz R. G.","family":"Britto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Ping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-1874","authenticated-orcid":false,"given":"Hong-Shuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,12]]},"reference":[{"key":"1656_CR1","doi-asserted-by":"publisher","unstructured":"Millar LJ, Shi L, Hoerder-Suabedissen A, Moln\u00e1r Z (2017) Neonatal hypoxia ischaemia: mechanisms, models, and therapeutic challenges. Front Cell Neurosci 78. \n                    https:\/\/doi.org\/10.3389\/fncel.2017.00078","DOI":"10.3389\/fncel.2017.00078"},{"key":"1656_CR2","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1056\/NEJMra041996","volume":"351","author":"DM Ferriero","year":"2004","unstructured":"Ferriero DM (2004) Neonatal Brain Injury. N Engl J Med 351:1985\u20131995. \n                    https:\/\/doi.org\/10.1056\/NEJMra041996","journal-title":"N Engl J Med"},{"key":"1656_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0022-3476(81)80555-0","volume":"98","author":"NN Finer","year":"1981","unstructured":"Finer NN, Robertson CM, Richards RT, Pinnell LE, Peters KL (1981) Hypoxic-ischemic encephalopathy in term neonates: Perinatal factors and outcome. J Pediatr 98:112\u2013117. \n                    https:\/\/doi.org\/10.1016\/S0022-3476(81)80555-0","journal-title":"J Pediatr"},{"key":"1656_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrneurol.2012.21","volume":"8","author":"HA Choi","year":"2012","unstructured":"Choi HA, Badjatia N, Mayer SA (2012) Hypothermia for acute brain injury\u2014mechanisms and practical aspects. Nat Rev Neurol 8:214\u2013222. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2012.21","journal-title":"Nat Rev Neurol"},{"key":"1656_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.clp.2009.07.011.Hypoxic","volume":"36","author":"A Fatemi","year":"2009","unstructured":"Fatemi A, Wilson MA, Michael VJ (2009) Hypoxic ischemic encephalopathy in the term infant. Clin Perinatol 36:835\u2013858. \n                    https:\/\/doi.org\/10.1016\/j.clp.2009.07.011.Hypoxic","journal-title":"Clin Perinatol"},{"key":"1656_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1515\/JPM.2005.061","volume":"33","author":"AJ Gunn","year":"2005","unstructured":"Gunn AJ, Battin M, Gluckman PD, Gunn TR, Bennet L (2005) Therapeutic hypothermia: from lab to NICU. J Perinat Med 33:340\u2013346. \n                    https:\/\/doi.org\/10.1515\/JPM.2005.061","journal-title":"J Perinat Med"},{"key":"1656_CR7","doi-asserted-by":"publisher","first-page":"e58834","DOI":"10.1371\/journal.pone.0058834","volume":"8","author":"SS Pauliah","year":"2013","unstructured":"Pauliah SS, Shankaran S, Wade A, Cady EB, Thayyil S (2013) Therapeutic hypothermia for neonatal encephalopathy in low- and middle-income countries: a systematic review and meta-analysis. PLoS One 8:e58834. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0058834","journal-title":"PLoS One"},{"key":"1656_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/187221310789895586","volume":"4","author":"K Savman","year":"2010","unstructured":"Savman K, Brown KL (2010) Treating neonatal brain injury\u2014promise and inherent research challenges. Recent Pat Inflamm Allergy Drug Discov 4:16\u201324","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"1656_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00018-003-3319-x","volume":"61","author":"M Arundine","year":"2004","unstructured":"Arundine M, Tymianski M (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61:657\u2013668. \n                    https:\/\/doi.org\/10.1007\/s00018-003-3319-x","journal-title":"Cell Mol Life Sci"},{"key":"1656_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tips.2008.02.003","volume":"29","author":"E Besancon","year":"2008","unstructured":"Besancon E, Guo S, Lok J, Tymianski M, Lo EH (2008) Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 29:268\u2013275. \n                    https:\/\/doi.org\/10.1016\/j.tips.2008.02.003","journal-title":"Trends Pharmacol Sci"},{"key":"1656_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2174\/156802606777057553","volume":"6","author":"M Hetman","year":"2006","unstructured":"Hetman M, Kharebava G (2006) Survival signaling pathways activated by NMDA receptors. Curr Top Med Chem 6:787\u2013799","journal-title":"Curr Top Med Chem"},{"key":"1656_CR12","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1161\/01.STR.0000025518.34157.51","volume":"33","author":"DJ Gladstone","year":"2002","unstructured":"Gladstone DJ, Black SE, Hakim AM (2002) Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123\u20132136. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000025518.34157.51","journal-title":"Stroke"},{"key":"1656_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00424-005-1439-x","volume":"451","author":"MM Aarts","year":"2005","unstructured":"Aarts MM, Tymianski M (2005) TRPMs and neuronal cell death. Pflugers Arch - Eur J Physiol 451:243\u2013249. \n                    https:\/\/doi.org\/10.1007\/s00424-005-1439-x","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"1656_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-540-34891-7_14","volume":"179","author":"J Eisfeld","year":"2007","unstructured":"Eisfeld J, L\u00fcckhoff A (2007) TRPM2. Handb Exp Pharmacol 179:237\u2013252. \n                    https:\/\/doi.org\/10.1007\/978-3-540-34891-7_14","journal-title":"Handb Exp Pharmacol"},{"key":"1656_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1517\/14728222.2010.510135","volume":"14","author":"L-H Jiang","year":"2010","unstructured":"Jiang L-H, Yang W, Zou J, Beech DJ (2010) TRPM2 channel properties, functions and therapeutic potentials. Expert Opin Ther Targets 14:973\u2013988. \n                    https:\/\/doi.org\/10.1517\/14728222.2010.510135","journal-title":"Expert Opin Ther Targets"},{"key":"1656_CR16","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1161\/STROKEAHA.114.005836","volume":"45","author":"M Gelderblom","year":"2014","unstructured":"Gelderblom M, Melzer N, Schattling B, G\u00f6b E, Hicking G, Arunachalam P, Bittner S, Ufer F et al (2014) Transient receptor potential melastatin subfamily member 2 cation channel regulates detrimental immune cell invasion in ischemic stroke. Stroke 45:3395\u20133402. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.005836","journal-title":"Stroke"},{"key":"1656_CR17","doi-asserted-by":"publisher","first-page":"11811","DOI":"10.1523\/JNEUROSCI.5251-14.2015","volume":"35","author":"Y Jang","year":"2015","unstructured":"Jang Y, Lee SH, Lee B, Jung S, Khalid A, Uchida K, Tominaga M, Jeon D et al (2015) TRPM2, a susceptibility gene for bipolar disorder, regulates glycogen synthase kinase-3 activity in the brain. J Neurosci 35:11811\u201311823. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5251-14.2015","journal-title":"J Neurosci"},{"key":"1656_CR18","doi-asserted-by":"publisher","first-page":"15157","DOI":"10.1523\/JNEUROSCI.4081-14.2015","volume":"35","author":"VG Ostapchenko","year":"2015","unstructured":"Ostapchenko VG, Chen M, Guzman MS, Xie Y-F, Lavine N, Fan J, Beraldo FH, Martyn AC et al (2015) The transient receptor potential melastatin 2 (TRPM2) channel contributes to \u03b2-amyloid oligomer-related neurotoxicity and memory impairment. J Neurosci 35:15157\u201315169. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4081-14.2015","journal-title":"J Neurosci"},{"key":"1656_CR19","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1113\/jphysiol.2010.201855","volume":"589","author":"A Sumoza-Toledo","year":"2011","unstructured":"Sumoza-Toledo A, Penner R (2011) TRPM2: a multifunctional ion channel for calcium signalling. J Physiol 589:1515\u20131525. \n                    https:\/\/doi.org\/10.1113\/jphysiol.2010.201855","journal-title":"J Physiol"},{"key":"1656_CR20","doi-asserted-by":"publisher","first-page":"17264","DOI":"10.1523\/JNEUROSCI.1729-13.2013","volume":"33","author":"I Alim","year":"2013","unstructured":"Alim I, Teves L, Li R, Mori Y, Tymianski M (2013) Modulation of NMDAR subunit expression by TRPM2 channels regulates neuronal vulnerability to ischemic cell death. J Neurosci 33:17264\u201317277. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1729-13.2013","journal-title":"J Neurosci"},{"key":"1656_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.expneurol.2017.06.023","volume":"296","author":"S Huang","year":"2017","unstructured":"Huang S, Turlova E, Li F, Bao M-H, Szeto V, Wong R, Abussaud A, Wang H et al (2017) Transient receptor potential melastatin 2 channels (TRPM2) mediate neonatal hypoxic-ischemic brain injury in mice. Exp Neurol 296:32\u201340. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2017.06.023","journal-title":"Exp Neurol"},{"key":"1656_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejphar.2014.08.023","volume":"742","author":"S Shimizu","year":"2014","unstructured":"Shimizu S, Yonezawa R, Hagiwara T, Yoshida T, Takahashi N, Hamano S, Negoro T, Toda T et al (2014) Inhibitory effects of AG490 on H2O2-induced TRPM2-mediated Ca2+entry. Eur J Pharmacol 742:22\u201330. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2014.08.023","journal-title":"Eur J Pharmacol"},{"key":"1656_CR23","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3390\/md13042505","volume":"13","author":"WL Chen","year":"2015","unstructured":"Chen WL, Turlova E, Sun CLF, Kim JS, Huang S, Zhong X, Guan YY, Wang GL et al (2015a) Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K\/Akt and MEK\/ERK signaling pathways. Mar Drugs 13:2505\u20132525. \n                    https:\/\/doi.org\/10.3390\/md13042505","journal-title":"Mar Drugs"},{"key":"1656_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13041-015-0102-5","volume":"8","author":"W Chen","year":"2015","unstructured":"Chen W, Xu B, Xiao A, Liu L, Fang X, Liu R, Turlova E, Barszczyk A et al (2015b) TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury. Mol Brain 8:11. \n                    https:\/\/doi.org\/10.1186\/s13041-015-0102-5","journal-title":"Mol Brain"},{"key":"1656_CR25","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1152\/jn.00970.2005","volume":"95","author":"H Sun","year":"2006","unstructured":"Sun H, Feng Z, Miki T, Seino S, French RJ, Feng Z, Miki T, Seino S et al (2006) Enhanced neuronal damage after ischemic insults in mice lacking Kir6.2-containing ATP-sensitive K+ channels. J Neurophysiol 95:2590\u20132601. \n                    https:\/\/doi.org\/10.1152\/jn.00970.2005","journal-title":"J Neurophysiol"},{"key":"1656_CR26","doi-asserted-by":"publisher","first-page":"16323","DOI":"10.1073\/pnas.0701149104","volume":"104","author":"W-L Wei","year":"2007","unstructured":"Wei W-L, Sun H-S, Olah ME, Sun X, Czerwinska E, Czerwinski W, Mori Y, Orser BA et al (2007) TRPM7 channels in hippocampal neurons detect levels of extracellular divalent cations. Proc Natl Acad Sci 104:16323\u201316328. \n                    https:\/\/doi.org\/10.1073\/pnas.0701149104","journal-title":"Proc Natl Acad Sci"},{"key":"1656_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ana.410090206","volume":"9","author":"JE Rice 3rd","year":"1981","unstructured":"Rice JE 3rd, Vannucci RC, Brierley JB (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131\u2013141. \n                    https:\/\/doi.org\/10.1002\/ana.410090206","journal-title":"Ann Neurol"},{"key":"1656_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.expneurol.2014.10.003","volume":"263","author":"HS Sun","year":"2015","unstructured":"Sun HS, Xu B, Chen W, Xiao A, Turlova E, Alibraham A, Barszczyk A, Bae CYJ et al (2015) Neuronal KATPchannels mediate hypoxic preconditioning and reduce subsequent neonatal hypoxic-ischemic brain injury. Exp Neurol 263:161\u2013171. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2014.10.003","journal-title":"Exp Neurol"},{"key":"1656_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/md13010029","volume":"13","author":"AJ Xiao","year":"2015","unstructured":"Xiao AJ, Chen W, Xu B, Liu R, Turlova E, Barszczyk A, Sun CL, Liu L et al (2015) Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury. Mar Drugs 13:29\u201347. \n                    https:\/\/doi.org\/10.3390\/md13010029","journal-title":"Mar Drugs"},{"key":"1656_CR30","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/aps.2018.1","volume":"39","author":"R Wong","year":"2018","unstructured":"Wong R, Abussaud A, Leung JW, Xu BF, Li FY, Huang S, Chen NH, Wang GL et al (2018) Blockade of the swelling-induced chloride current attenuates the mouse neonatal hypoxic-ischemic brain injury in vivo. Acta Pharmacol Sin 39:858\u2013865. \n                    https:\/\/doi.org\/10.1038\/aps.2018.1","journal-title":"Acta Pharmacol Sin"},{"key":"1656_CR31","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1007\/s12035-015-9488-4","volume":"53","author":"B Xu","year":"2016","unstructured":"Xu B, Xiao A-J, Chen W, Turlova E, Liu R, Barszczyk A, Sun CLF, Liu L et al (2016) Neuroprotective effects of a PSD-95 inhibitor in neonatal hypoxic-ischemic brain injury. Mol Neurobiol 53:5962\u20135970. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9488-4","journal-title":"Mol Neurobiol"},{"key":"1656_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbr.2004.06.019","volume":"157","author":"A Lubics","year":"2005","unstructured":"Lubics A, Reglodi D, Tam\u00e1s A, Kiss P, Szalai M, Szalontay L, Lengv\u00e1ri I (2005) Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic-ischemic injury. Behav Brain Res 157:157\u2013165. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2004.06.019","journal-title":"Behav Brain Res"},{"key":"1656_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0091-3057(88)90163-3","volume":"29","author":"C Castellano","year":"1988","unstructured":"Castellano C, Pavone F (1988) Effects of ethanol on passive avoidance behavior in the mouse: involvement of GABAergic mechanisms. Pharmacol Biochem Behav 29:321\u2013324. \n                    https:\/\/doi.org\/10.1016\/0091-3057(88)90163-3","journal-title":"Pharmacol Biochem Behav"},{"key":"1656_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2466\/pr0.1967.21.1.221","volume":"21","author":"ME Jarvik","year":"1967","unstructured":"Jarvik ME, Kopp R (1967) An improved one-trial passive avoidance learning situation. Psychol Rep 21:221\u2013224. \n                    https:\/\/doi.org\/10.2466\/pr0.1967.21.1.221","journal-title":"Psychol Rep"},{"key":"1656_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvu112","volume":"103","author":"S Roberge","year":"2014","unstructured":"Roberge S, Roussel J, Andersson DC, Meli AC, Vidal B, Blandel F, Lanner JT, Le Guennec JY et al (2014) TNF-alpha-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes. Cardiovasc Res 103:90\u201399. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvu112","journal-title":"Cardiovasc Res"},{"key":"1656_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature05453","volume":"445","author":"Allen Institute for Brain Science","year":"2015","unstructured":"Allen Institute for Brain Science (2015) Allen mouse brain atlas. Allen Mouse Brain Atlas 445:168\u2013176. \n                    https:\/\/doi.org\/10.1038\/nature05453","journal-title":"Allen Mouse Brain Atlas"},{"key":"1656_CR37","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.1523\/JNEUROSCI.5746-12.2013","volume":"33","author":"AD Workman","year":"2013","unstructured":"Workman AD, Charvet CJ, Clancy B, Darlington RB, Finlay BL (2013) Modeling transformations of neurodevelopmental sequences across mammalian species. J Neurosci 33:7368\u20137383. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5746-12.2013","journal-title":"J Neurosci"},{"key":"1656_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12950-016-0126-3","volume":"13","author":"HT Chai","year":"2016","unstructured":"Chai HT, Yip HK, Sun CK, Hsu SY, Leu S (2016) AG490 suppresses EPO-mediated activation of JAK2-STAT but enhances blood flow recovery in rats with critical limb ischemia. J Inflamm (United Kingdom) 13:18. \n                    https:\/\/doi.org\/10.1186\/s12950-016-0126-3","journal-title":"J Inflamm (United Kingdom)"},{"key":"1656_CR39","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s10875-012-9707-y","volume":"32","author":"A Davoodi-Semiromi","year":"2012","unstructured":"Davoodi-Semiromi A, Hassanzadeh A, Wasserfall CH, Droney A, Atkinson M (2012) Tyrphostin AG490 agent modestly but significantly prevents onset of type 1 in NOD mouse; implication of immunologic and metabolic effects of a Jak-stat pathway inhibitor. J Clin Immunol 32:1038\u20131047. \n                    https:\/\/doi.org\/10.1007\/s10875-012-9707-y","journal-title":"J Clin Immunol"},{"key":"1656_CR40","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.healun.2004.11.017","volume":"24","author":"T Higuchi","year":"2005","unstructured":"Higuchi T, Shiraishi T, Shirakusa T, Hirayama S, Shibaguchi H, Kuroki M, Hiratuka M, Yamamoto S et al (2005) Prevention of acute lung allograft rejection in rat by the Janus kinase 3 inhibitor, tyrphostin AG490. J Heart Lung Transplant 24:1557\u20131564. \n                    https:\/\/doi.org\/10.1016\/j.healun.2004.11.017","journal-title":"J Heart Lung Transplant"},{"key":"1656_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2016.05.033","volume":"786","author":"T Toda","year":"2016","unstructured":"Toda T, Yamamoto S, Yonezawa R, Mori Y, Shimizu S (2016) Inhibitory effects of tyrphostin AG-related compounds on oxidative stress-sensitive transient receptor potential channel activation. Eur J Pharmacol 786:19\u201328. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2016.05.033","journal-title":"Eur J Pharmacol"},{"key":"1656_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12035-014-9032-y","volume":"53","author":"E Turlova","year":"2016","unstructured":"Turlova E, Bae CYJ, Deurloo M, Chen W, Barszczyk A, Horgen FD, Fleig A, Feng ZP et al (2016) TRPM7 regulates axonal outgrowth and maturation of primary hippocampal neurons. Mol Neurobiol 53:595\u2013610. \n                    https:\/\/doi.org\/10.1007\/s12035-014-9032-y","journal-title":"Mol Neurobiol"},{"key":"1656_CR43","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.bbagen.2016.06.027","volume":"1860","author":"H Wang","year":"2016","unstructured":"Wang H, Huang S, Yan K, Fang X, Abussaud A, Martinez A, Sun HS, Feng ZP (2016) Tideglusib, a chemical inhibitor of GSK3\u03b2, attenuates hypoxic-ischemic brain injury in neonatal mice. Biochim Biophys Acta-Gen Subj 1860:2076\u20132085. \n                    https:\/\/doi.org\/10.1016\/j.bbagen.2016.06.027","journal-title":"Biochim Biophys Acta-Gen Subj"},{"key":"1656_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1083\/jcb.151.3.483","volume":"151","author":"H Zhou","year":"2000","unstructured":"Zhou H, Li XM, Meinkoth J, Pittman RN (2000) Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 151:483\u2013494. \n                    https:\/\/doi.org\/10.1083\/jcb.151.3.483","journal-title":"J Cell Biol"},{"key":"1656_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ana.23647","volume":"72","author":"JJ Volpe","year":"2012","unstructured":"Volpe JJ (2012) Neonatal encephalopathy: An inadequate term for hypoxic-ischemic encephalopathy. Ann Neurol 72:156\u2013166. \n                    https:\/\/doi.org\/10.1002\/ana.23647","journal-title":"Ann Neurol"},{"key":"1656_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0014-4886(89)90162-3","volume":"106","author":"JW McDonald","year":"1989","unstructured":"McDonald JW, Roeser NF, Silverstein FS, Johnston MV (1989) Quantitative assessment of neuroprotection against NMDA-induced brain injury. Exp Neurol 106:289\u2013296. \n                    https:\/\/doi.org\/10.1016\/0014-4886(89)90162-3","journal-title":"Exp Neurol"},{"key":"1656_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0304-394(89)90265-6","volume":"99","author":"A Represa","year":"1989","unstructured":"Represa A, Tremblay E, Ben-Ari Y (1989) Transient increase of NMDA-binding sites in human hippocampus during development. Neurosci Lett 99:61\u201366. \n                    https:\/\/doi.org\/10.1016\/0304-394(89)90265-6","journal-title":"Neurosci Lett"},{"key":"1656_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0006-8993(88)90275-2","volume":"461","author":"E Tremblay","year":"1988","unstructured":"Tremblay E, Roisin MP, Represa A, Charriaut-Marlangue C, Ben-Ari Y (1988) Transient increased density of NMDA binding sites in the developing rat hippocampus. Brain Res 461:393\u2013396. \n                    https:\/\/doi.org\/10.1016\/0006-8993(88)90275-2","journal-title":"Brain Res"},{"key":"1656_CR49","first-page":"597","volume":"50","author":"W Danysz","year":"1998","unstructured":"Danysz W, Parsons CG (1998) Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597\u2013664","journal-title":"Pharmacol Rev"},{"key":"1656_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0304-3940(87)90379-X","volume":"78","author":"H Hagberg","year":"1987","unstructured":"Hagberg H, Andersson P, Kjellmer I, Thiringer K, Thordstein M (1987) Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Neurosci Lett 78:311\u2013317. \n                    https:\/\/doi.org\/10.1016\/0304-3940(87)90379-X","journal-title":"Neurosci Lett"},{"key":"1656_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0887-8994(92)90050-9","volume":"8","author":"RS Riikonen","year":"1992","unstructured":"Riikonen RS, Kero PO, Simell OG (1992) Excitatory amino acids in cerebrospinal fluid in neonatal asphysia. Pediatr Neurol 8:37\u201340. \n                    https:\/\/doi.org\/10.1016\/0887-8994(92)90050-9","journal-title":"Pediatr Neurol"},{"key":"1656_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0387-7604(12)80037-4","volume":"13","author":"GL Holmes","year":"1991","unstructured":"Holmes GL (1991) The long-term effects of seizures on the developing brain: clinical and laboratory issues. Brain Dev 13:393\u2013409. \n                    https:\/\/doi.org\/10.1016\/S0387-7604(12)80037-4","journal-title":"Brain Dev"},{"key":"1656_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1203\/00006450-200103000-00004","volume":"49","author":"GL Holmes","year":"2001","unstructured":"Holmes GL, Ben-Ari Y, Zipursky A (2001) The neurobiology and consequences of epilepsy in the developing brain. Pediatr Res 49:320\u2013325. \n                    https:\/\/doi.org\/10.1203\/00006450-200103000-00004","journal-title":"Pediatr Res"},{"key":"1656_CR54","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1203\/01.pdr.0000214891.35363.6a","volume":"59","author":"MJ Lafemina","year":"2006","unstructured":"Lafemina MJ, Sheldon RA, Ferriero DM (2006) Acute hypoxia-ischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr Res 59:680\u2013683. \n                    https:\/\/doi.org\/10.1203\/01.pdr.0000214891.35363.6a","journal-title":"Pediatr Res"},{"key":"1656_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1254\/jphs.FP0060128","volume":"101","author":"S Kaneko","year":"2006","unstructured":"Kaneko S, Kawakami S, Hara Y, Wakamori M, Itoh E, Minami T, Takada Y, Kume T et al (2006) A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J Pharmacol Sci 101:66\u201376","journal-title":"J Pharmacol Sci"},{"key":"1656_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4196\/kjpp.2009.13.2.131","volume":"13","author":"IA Seo","year":"2009","unstructured":"Seo IA, Lee HK, Shin YK, Lee SH, Seo S-Y, Park JW, Park HT (2009) Janus kinase 2 inhibitor AG490 inhibits the STAT3 signaling pathway by suppressing protein translation of gp130. Korean J Physiol Pharmacol 13:131\u2013138. \n                    https:\/\/doi.org\/10.4196\/kjpp.2009.13.2.131","journal-title":"Korean J Physiol Pharmacol"},{"key":"1656_CR57","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/35088074","volume":"412","author":"M Digicaylioglu","year":"2001","unstructured":"Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-\u03baB signalling cascades. Nature 412:641\u2013647. \n                    https:\/\/doi.org\/10.1038\/35088074","journal-title":"Nature"},{"key":"1656_CR58","doi-asserted-by":"publisher","first-page":"12047","DOI":"10.1523\/JNEUROSCI.1800-15.2015","volume":"35","author":"S Guo","year":"2015","unstructured":"Guo S, Li Z-Z, Gong J, Xiang M, Zhang P, Zhao G-N, Li M, Zheng A et al (2015) Oncostatin M confers neuroprotection against ischemic stroke. J Neurosci 35:12047\u201312062. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1800-15.2015","journal-title":"J Neurosci"},{"key":"1656_CR59","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1471-4159.2006.04051.x","volume":"98","author":"I Satriotomo","year":"2006","unstructured":"Satriotomo I, Bowen KK, Vemuganti R (2006) JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem 98:1353\u20131368. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04051.x","journal-title":"J Neurochem"},{"key":"1656_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000484585","volume":"44","author":"X-L Wang","year":"2017","unstructured":"Wang X-L, Qiao C-M, Liu J-O, Li C-Y (2017) Inhibition of the SOCS1-JAK2-STAT3 signaling pathway confers neuroprotection in rats with ischemic stroke. Cell Physiol Biochem 44:85\u201398. \n                    https:\/\/doi.org\/10.1159\/000484585","journal-title":"Cell Physiol Biochem"},{"key":"1656_CR61","doi-asserted-by":"publisher","first-page":"e3003","DOI":"10.1038\/cddis.2017.381","volume":"8","author":"S-J Yoo","year":"2017","unstructured":"Yoo S-J, Cho B, Lee D, Son G, Lee Y-B, Soo Han H, Kim E, Moon C et al (2017) The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage. Cell Death Dis 8:e3003. \n                    https:\/\/doi.org\/10.1038\/cddis.2017.381","journal-title":"Cell Death Dis"},{"key":"1656_CR62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2013.05.043","volume":"714","author":"H Zhu","year":"2013","unstructured":"Zhu H, Zou L, Tian J, Du G, Gao Y (2013) SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2\/STAT3 pathway. Eur J Pharmacol 714:23\u201331. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2013.05.043","journal-title":"Eur J Pharmacol"},{"key":"1656_CR63","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s10495-007-0065-9","volume":"12","author":"Y Wu","year":"2007","unstructured":"Wu Y, Shang Y, Sun S, Liang H, Liu R (2007) Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt\/GSK-3\u03b2\/caspase-3 mediated signaling pathway. Apoptosis 12:1365\u20131375. \n                    https:\/\/doi.org\/10.1007\/s10495-007-0065-9","journal-title":"Apoptosis"},{"key":"1656_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148:114\u2013131. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.016","journal-title":"Pharmacol Ther"},{"key":"1656_CR65","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","volume":"32","author":"RS Jope","year":"2007","unstructured":"Jope RS, Yuskaitis CJ, Beurel E (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 32:577\u2013595. \n                    https:\/\/doi.org\/10.1007\/s11064-006-9128-5","journal-title":"Neurochem Res"},{"key":"1656_CR66","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1089\/neu.2015.4177","volume":"33","author":"SS Shim","year":"2016","unstructured":"Shim SS, Stutzmann GE (2016) Inhibition of glycogen synthase kinase-3: an emerging target in the treatment of traumatic brain injury. J Neurotrauma 33:2065\u20132076. \n                    https:\/\/doi.org\/10.1089\/neu.2015.4177","journal-title":"J Neurotrauma"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01656-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01656-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01656-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T23:12:36Z","timestamp":1591830756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01656-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,12]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1656"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01656-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,12]]},"assertion":[{"value":"31 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}